Valley Cottage, NY, Oct. 16, 2017 -- Flow cytometry is used to monitor microscopic particles with the help of electronic devices called flow cytometers. Flow cytometry is used in stem cell research, in the development of immunology products and vaccines and also in CD4 testing. The global flow cytometry market is influenced by various factors such as medical and technological developments in flow cytometry products, rising use of flow cytometry in clinical trials, in detection of blood cancer, in research, in launching of new reagents for critical applications such as drug discovery and diagnostics and also in development of intuitive and user-friendly software are fuelling the growth of the flow cytometry market in the forthcoming timeline. Moreover, rising prevalence of AIDS and cancer has triggered the adoption of flow cytometry technology in scientific research. This is supporting the growth of the global flow cytometry market.
The analytical and extensive research report on “Flow Cytometry Market: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2022)” published by Future Market Insights uncovers various factors of the global market for flow cytometry which can be used to analyse and grasp opportunities in the market across regions worldwide in order to carry out expansion programs in the future. According to the market analysis in this research report, the global flow cytometry market is projected to grow at a VAGR of 7.1% during the period of assessment 2017-2022.
Browse Research Report: https://www.futuremarketinsights.com/reports/flow-cytometry-market
5 Key Highlights on the Global Flow Cytometry Market
The global flow cytometry market is segmented by application, end user, technology, product type and region.
- By application, the research segment is expected to dominate the global market with respect to high market share. By the end of 2022, this segment is estimated to reach a high market valuation of around US$ 1.8 Bn growing at a high CAGR during this period. The industrial segment is projected to grow at the highest rate during the assessment period and poised to gain a high BPS by the end of 2022.
- By technology, the cell based segment is the largest segment. It is projected to grow at a CAGR of 7.2% throughout the period of forecast and is estimated to gain a very high valuation during the period of assessment.
- North America region is a highly lucrative region for the growth of the global flow cytometry market. The market in North America is soaring at a higher pace and expected to surpass other regions.
- By end user, the commercial organizations segment is expected to gain the highest BPS by end of 2022. Moreover, this segment demands increasing use of flow cytometry and is the largest and the fastest growing segment in the flow cytometry market.
- In the product type category, the reagents and consumables have gained high traction in the recent years. This segment is a high contributor of growth of the global flow cytometry market. The reagents and consumables segment is estimated to gain a high BPS and grow at a high CAGR of 7.9% throughout the period of assessment.
Get Sample of this Research Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-5263
Global Flow Cytometry Market: Competitive Landscape
The global flow cytometry market research study includes a separate section on competitive landscape in which it focuses on the key players and their in-depth analysis including company overview, SWOT analysis, developments, innovations, key financials and product portfolios. This extensive research report covers key companies such as Miltenyi Biotec GmbH, General Electric Company, Luminex Corporation, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Merck & Co Inc., Agilent Technologies, Inc., Sysmex Corporation, Becton Dickinson and Company and Danaher Corporation.
Request ToC of Report: https://www.futuremarketinsights.com/reports/flow-cytometry-market/toc
About Us
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights and an aerial view of the competitive framework and future market trends.
Future Market Insights 616 Corporate Way, Suite 2-9018, Valley Cottage, NY 10989, United States T: +1-347-918-3531 F: +1-845-579-5705 T (UK): +44(0)20-7692-8790 Sales: [email protected] Website: http://www.futuremarketinsights.com


FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Washington Post Publisher Will Lewis Steps Down After Layoffs
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 



